Co-Diagnostics, Inc.
(NASDAQ : CODX)

( )
CODX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.26%203.421.3%$752.26m
GILDGilead Sciences, Inc.
0.14%64.220.9%$374.75m
CELGCelgene Corporation
0.03%95.711.3%$325.97m
ALXNAlexion Pharmaceuticals, Inc.
7.53%123.492.0%$306.94m
ILMNIllumina, Inc.
-0.66%288.583.5%$277.12m
BIIBBiogen Inc.
-0.48%232.061.3%$268.05m
VRTXVertex Pharmaceuticals Incorporated
-1.16%184.241.9%$256.63m
EXASExact Sciences Corporation
-1.14%117.8724.1%$239.89m
REGNRegeneron Pharmaceuticals, Inc.
-0.93%295.022.6%$203.40m
AAgilent Technologies, Inc.
-0.69%71.701.6%$193.78m
SRPTSarepta Therapeutics, Inc.
-6.34%95.0714.7%$184.59m
BMRNBioMarin Pharmaceutical Inc.
-1.05%77.404.3%$97.47m
INCYIncyte Corporation
-0.59%85.562.5%$96.06m
GHDXGenomic Health, Inc.
-1.12%73.521.8%$85.99m
SGENSeattle Genetics, Inc.
-2.01%78.366.5%$79.57m

Company Profile

Co-Diagnostics, Inc. is a molecular diagnostics company, which engages in the development, manufacture, and marketing of diagnostics technology. The company's products are utilized for tests that are designed using the detection and analysis of nucleic acid molecules. It also uses its proprietary technology to design tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.